InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Lee Joyce J., 董事. Officer active across 2 companies, notably Elanco Animal Health Inc. Aggregated, 4 disclosures have been published. Activity tracked since 30 November 2021. The latest transaction was filed on 8 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lee Joyce J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
540 股0Common StockSEC:0001140361-24-007128:0
530 股0Common StockSEC:0001140361-23-006026:0
509 股0Common StockSEC:0001140361-22-005096:0
1,153 股@ US$28.74100.0% 占其流量Common StockSEC:0001179110-21-010537:0
4 条申报中的 4 条
About Lee Joyce J.
Lee Joyce J. is Executive Vice President of Pet Health Commercial Operations at Elanco Animal Health Inc and Balchem Corp. She oversees operations and contributes to the growth strategy of both companies.
